Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO

Mike Grey four years ago sold Lumena Pharmaceuticals Inc. — including two drugs targeting liver diseases — to Shire plc. On Friday, his new Peninsula company filed for an $86.25 million initial public offering to take those same two drugs deeper into the clinical trials.

Mirum Pharmaceuticals Inc., a 24-employee company in Foster City, said in a Securities and Exchange Commission filing that it expects to use the money to complete a late-stage clinical trial of the drug maralixibat and start…

Previous St. Louis law firm sues over Roundup advertising
Next Longstanding Shelby’s Bar officially closed downtown, makes way for a pair of condo towers

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *